{"organizations": [], "uuid": "bd5fe2d8f4184c1b0e041e837d827dbf1b1eba67", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180419.html", "section_title": "Archive News &amp; Video for Thursday, 19 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-takeda-says-shire-rejected-revised/brief-takeda-says-shire-rejected-revised-proposal-of-46-50-pounds-per-share-idUSL8N1RW4AY", "country": "US", "domain_rank": 408, "title": "BRIEF-Takeda Says Shire Rejected Revised Proposal of 46.50 Pounds Per Share", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.002, "site_type": "news", "published": "2018-04-19T20:13:00.000+03:00", "replies_count": 0, "uuid": "bd5fe2d8f4184c1b0e041e837d827dbf1b1eba67"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-takeda-says-shire-rejected-revised/brief-takeda-says-shire-rejected-revised-proposal-of-46-50-pounds-per-share-idUSL8N1RW4AY", "ord_in_thread": 0, "title": "BRIEF-Takeda Says Shire Rejected Revised Proposal of 46.50 Pounds Per Share", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "takeda", "sentiment": "negative"}, {"name": "shire plc", "sentiment": "none"}, {"name": "takeda pharmaceutical co ltd", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 19 (Reuters) - TAKEDA PHARMACEUTICAL CO LTD:\n* TAKEDA - TAKEDA WAS NOTIFIED THAT BOARD OF SHIRE HAD REJECTED ITS PROPOSAL\n* TAKEDA PHARMACEUTICAL CO LTD - TAKEDA STATEMENT REGARDING SHIRE PLC\n* TAKEDA PHARMACEUTICAL CO LTD - CONFIRMS THAT ON APRIL 12 IT MADE A REVISED PROPOSAL TO BOARD OF SHIRE\n* TAKEDA - DISCUSSIONS BETWEEN PARTIES REGARDING A POTENTIAL OFFER ARE ONGOING\n* TAKEDA PHARMACEUTICAL CO LTD - REVISED PROPOSAL TO BOARD OF SHIRE TO ACQUIRE SHARE CAPITAL OF SHIRE FOR A PRICE EQUIVALENT TO £46.50 PER SHARE\n* TAKEDA PHARMACEUTICAL CO LTD - REVISED PROPOSAL TO BOARD OF SHIRE COMPRISED OF £17.75 IN CASH (TO BE PAID IN US$) AND £28.75 OF NEW TAKEDA SHARES.\n* TAKEDA - PROPOSAL DOES NOT CONSTITUTE AN OFFER OR IMPOSE ANY OBLIGATION ON TAKEDA TO MAKE AN OFFER, NOR DOES IT EVIDENCE A FIRM INTENTION TO MAKE AN OFFER\n* TAKEDA PHARMACEUTICAL CO LTD - TAKEDA INTENDS TO MAINTAIN ITS WELL-ESTABLISHED DIVIDEND POLICY AND INVESTMENT GRADE CREDIT RATING\n* TAKEDA - TAKEDA WAS SUBSEQUENTLY NOTIFIED THAT BOARD OF SHIRE HAD REJECTED ITS PROPOSAL Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-19T20:13:00.000+03:00", "crawled": "2018-04-20T11:31:58.004+03:00", "highlightTitle": ""}